Dr. Sola Adeleke MRCP, MBA, PhD

Founder/CEO

Driving developments at Curenetics, Sola is a practicing Oncologist. With a research interest focused on the development of quantitative MR-derived biomarkers for response assessment in prostate cancer, Sola is well-positioned to guide the Curenetics team. Sola obtained a PhD in magnetic resonance imaging from University College London.